Steven Paul

Steven Paul

Förmögenhet: 40 M $ per 2026-06-30

75 år
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Steven M.
Paul, MD, is a Chairman at Seaport Therapeutics, Inc., a Chairman at Rapport Therapeutics, Inc., a Chairman & Director at Tal Medical, Inc., a Venture Partner at Third Rock Ventures LLC, a Chairman at Foundation for the National Institutes of Health, Inc., a Member at National Academy of Medicine (United States), a Member at National Academy of Sciences and a Professor at Saint Louis University School of Medicine.
He is on the Board of Directors at Syremis Therapeutics Ltd., Tal Medical, Inc., Biotechnology Innovation Organization, Butler University, Eli Lilly & Co. Foundation, Inc., Flare Therapeutics, Inc., Indianapolis Zoological Society, Inc., Seaside Therapeutics LLC, The Allen Institute for Brain Science and The Mind Research Network.
Dr. Paul was previously employed as a Member-Science Board by US Food & Drug Administration, an Independent Director by Alnylam Pharmaceuticals, Inc., a Professor by Weill Cornell Medical College, an Independent Director by SAGE Therapeutics, Inc., a President by Lilly Research Laboratories, an Executive Vice President-Science & Technology by Eli Lilly & Co., a Scientific Director by National Institute of Mental Health, a President by American College of Neuropsychopharmacology, a Member by National Institute of General Medical Sciences, a Member by The National Advisory Mental Health Council, and a Medical Director-Commissioned Corps by US Public Health Service.
He also served on the board at Karuna Therapeutics, Inc., Alliance for Regenerative Medicine, Voyager Therapeutics, Inc., Constellation Pharmaceuticals, Inc., ImClone LLC, National Institutes of Health, BioCrossroads, DemeRx, Inc., Helen & Robert Appel Alzheimers Disease Research Institute and Sigma-Aldrich Co. LLC (Missouri).
He received his undergraduate degree from Tulane University (Louisiana), a graduate degree from Tulane University School of Medicine and a doctorate degree from Tulane University School of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-06-10 519 308 ( 1,09 % ) 22 M $ 2026-06-30
1,61 %
2026-05-04 863 031 ( 1,61 % ) 19 M $ 2026-06-30

Aktiva positioner av Steven Paul

FöretagPositionStart
RAPPORT THERAPEUTICS, INC. Grundare 2022-02-01
Företagsledare/Principal -
Företagsledare/Principal -
Direktör/Styrelseledamot -
Företagsledare/Principal -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Grundare 2010-01-01
Direktör/Styrelseledamot -

Tidigare kända positioner av Steven Paul

FöretagPositionSlut
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Steven Pauls erfarenhet

Steven Pauls utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

80

Första gradens relationer

38

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag38

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Government

Government

Commercial Services

Commercial Services

Commercial Services

Finance

Commercial Services

Commercial Services

Eli Lilly & Co. Foundation, Inc.

Commercial Services

Finance

Government

Health Technology

Distribution Services

Consumer Services

Government

Health Services

Commercial Services

Health Technology

Government

Health Services

Health Technology

Health Technology

Consumer Services

The National Advisory Mental Health Council

Consumer Services

Commercial Services

Helen & Robert Appel Alzheimers Disease Research Institute

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Steven Paul